These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 30689582)
1. Higher Apolipoprotein C-III Levels in Cerebrospinal Fluid are Associated with Slower Cognitive Decline in Mild Cognitive Impairment. Wang Q; Zhou W; Zhang J; J Alzheimers Dis; 2019; 67(3):961-969. PubMed ID: 30689582 [TBL] [Abstract][Full Text] [Related]
2. Higher Plasma APOC-III Was Associated with a Slower Reduction of β-Amyloid Levels in Cerebrospinal Fluid Among Older Individuals Without Dementia. Zhang X; Neuropsychiatr Dis Treat; 2020; 16():1139-1144. PubMed ID: 32440128 [TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer's disease. Pillai JA; Bena J; Bekris L; Kodur N; Kasumov T; Leverenz JB; Kashyap SR; Alzheimers Res Ther; 2023 Mar; 15(1):54. PubMed ID: 36927447 [TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type. Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336 [TBL] [Abstract][Full Text] [Related]
5. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies. Podhorna J; Krahnke T; Shear M; Harrison JE; Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820 [TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease. Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S; Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118 [TBL] [Abstract][Full Text] [Related]
8. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia. Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536 [TBL] [Abstract][Full Text] [Related]
9. Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer's disease biomarker related cognitive decline? Ye BS; Lee WW; Ham JH; Lee JJ; Lee PH; Sohn YH; Eur J Neurol; 2016 May; 23(5):948-57. PubMed ID: 26917248 [TBL] [Abstract][Full Text] [Related]
10. Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia. Oikonomidi A; Tautvydaitė D; Gholamrezaee MM; Henry H; Bacher M; Popp J J Alzheimers Dis; 2017; 60(1):273-281. PubMed ID: 28826184 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly. Slot RE; Van Harten AC; Kester MI; Jongbloed W; Bouwman FH; Teunissen CE; Scheltens P; Veerhuis R; van der Flier WM J Alzheimers Dis; 2017; 56(2):687-697. PubMed ID: 28035918 [TBL] [Abstract][Full Text] [Related]
12. Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer's disease. Baldeiras I; Santana I; Leitão MJ; Vieira D; Duro D; Mroczko B; Kornhuber J; Lewczuk P Alzheimers Res Ther; 2019 Jan; 11(1):2. PubMed ID: 30611311 [TBL] [Abstract][Full Text] [Related]
13. In Brief Neuropsychological Assessment, Amnestic Mild Cognitive Impairment (MCI) Is associated with Cerebrospinal Fluid Biomarkers for Cognitive Decline in Contrast to the Prevailing NIA-AA MCI Criterion. Hessen E; Kirsebom BE; Eriksson CM; Eliassen CF; Nakling AE; Bråthen G; Waterloo KK; Aarsland D; Fladby T J Alzheimers Dis; 2019; 67(2):715-723. PubMed ID: 30614807 [TBL] [Abstract][Full Text] [Related]
14. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease. Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875 [TBL] [Abstract][Full Text] [Related]
15. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample. Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924 [TBL] [Abstract][Full Text] [Related]
16. Association of cerebrospinal fluid Neurogranin with Alzheimer's disease. Wang L; Aging Clin Exp Res; 2019 Feb; 31(2):185-191. PubMed ID: 29667155 [TBL] [Abstract][Full Text] [Related]